Protein kinase inhibitor ceritinib blocks ectonucleotidase CD39 – a promising target for cancer immunotherapyLaura Schäkel, Christa E. Müller, Salahuddin Mirza et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 34